• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BriaCell Therapeutics Corp

ACP:CN

Ticker Change

Company Profile for BriaCell Therapeutics Corp (ACP)

BriaCell Therapeutics Corp. operates as a breast cancer immunotherapy biotech research and developer. The Company developed a patented whole-cell vaccine, cancer immunotherapy technology called the "BriaVax" vaccine. BriaCell has offices in North America.

Contact Information

BriaCell Therapeutics Corp

Bellevue Center 235
15th Street
Vancouver, BC V7T 2X1
Canada
Phone: 1-604-921-1810
Fax: 1-604-921-1898

Key Executives for BriaCell Therapeutics Corp (ACP)

Jevin WerbesPresident/CEOMatthew G WrightChief Financial Officer
Beverley Funston "Bev"Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil